This is a StreetInsider.com Premium Only Page

(DTIL) –

Apr 22, 2024 09:13 PM Form 4 PRECISION BIOSCIENCES For: Apr 18 Filed by: Amoroso Michael

Apr 22, 2024 09:13 PM Form 4 PRECISION BIOSCIENCES For: Apr 18 Filed by: Kelly John Alexander

Apr 22, 2024 09:13 PM Form 4 PRECISION BIOSCIENCES For: Apr 18 Filed by: SMITH J. JEFFERSON

Apr 22, 2024 09:13 PM Form 4 PRECISION BIOSCIENCES For: Apr 18 Filed by: Scimeca Dario

Apr 16, 2024 04:48 PM Form 8-K PRECISION BIOSCIENCES For: Apr 11

Apr 16, 2024 04:15 PM Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics

Apr 4, 2024 11:00 AM iECURE Announces FDA Clearance of Investigational New Drug Application for ECUR-506 to Initiate OTC-HOPE Trial for Treatment of Neonatal Onset Ornithine Transcarbamylase Deficiency in the U.S.

Apr 1, 2024 06:54 AM Precision BioSciences Inc. (DTIL) PT Raised to $60 at H.C. Wainwright

Mar 27, 2024 07:16 AM Form 10-K PRECISION BIOSCIENCES For: Dec 31

Mar 27, 2024 07:15 AM Form 8-K PRECISION BIOSCIENCES For: Mar 27

Mar 27, 2024 06:45 AM Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update

Mar 20, 2024 04:30 PM Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024

Mar 20, 2024 12:37 PM Precision BioSciences (DTIL) PT Raised to $30 at Jones Trading adjusting for reverse stock split

Mar 19, 2024 07:01 AM Precision BioSciences (DTIL) Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy

Mar 19, 2024 07:00 AM Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy

Mar 18, 2024 05:29 PM Form SC 13G PRECISION BIOSCIENCES Filed by: Aquilo Capital Management, LLC

Mar 14, 2024 04:14 PM Form SC 13G PRECISION BIOSCIENCES Filed by: PERCEPTIVE ADVISORS LLC

Mar 11, 2024 11:21 AM Form SC 13G PRECISION BIOSCIENCES Filed by: JANUS HENDERSON GROUP PLC

Mar 6, 2024 08:45 AM Precision BioSciences (DTIL) Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial

Mar 6, 2024 08:45 AM Precision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC Deficiency

Mar 6, 2024 08:00 AM iECURE Secures Approval from U.K. Medicines & Healthcare Products Regulatory Agency to Expand the OTC-HOPE Study of ECUR-506

Mar 4, 2024 06:02 AM Form 424B5 PRECISION BIOSCIENCES

Mar 1, 2024 08:00 AM Form 8-K PRECISION BIOSCIENCES For: Mar 01

Mar 1, 2024 06:31 AM Precision BioSciences (DTIL) Announces 2.5M Share Offering at $16/sh

Mar 1, 2024 06:30 AM Precision BioSciences Announces $40.0 Million Offering of Common Stock and Warrants

Mar 1, 2024 06:16 AM Form FWP PRECISION BIOSCIENCES Filed by: PRECISION BIOSCIENCES INC

Feb 29, 2024 05:22 PM Form 424B5 PRECISION BIOSCIENCES

Feb 29, 2024 04:01 PM Precision BioSciences (DTIL) Announces Proposed Public Offering of Common Stock and Warrants

Feb 29, 2024 04:01 PM Precision BioSciences Announces Proposed Public Offering of Common Stock and Warrants

Feb 20, 2024 07:10 AM Precision BioSciences (DTIL) Announces Non-Exclusive Patent License Agreement with Caribou Biosciences

Feb 20, 2024 07:00 AM Precision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciences

Feb 14, 2024 04:37 PM Form SC 13G/A PRECISION BIOSCIENCES Filed by: GREAT POINT PARTNERS LLC

Feb 14, 2024 07:01 AM Precision BioSciences (DTIL) Receives Pre-IND Feedback from US FDA for PBGENE-HBV

Feb 14, 2024 07:00 AM Precision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readiness

Feb 13, 2024 08:30 AM Form 8-K PRECISION BIOSCIENCES For: Feb 13

Feb 13, 2024 07:00 AM Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations

Feb 12, 2024 11:01 AM Form SC 13G/A PRECISION BIOSCIENCES Filed by: Capital World Investors

Feb 12, 2024 07:02 AM Precision BioSciences (DTIL) Receives $7.5M Payment and Equity Investment from TG Therapeutics (TGTX) over Azel-Cel

Feb 12, 2024 07:00 AM Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases

Feb 9, 2024 07:00 AM Precision BioSciences (DTIL) Announces 1:30 Reverse Share Split

Feb 9, 2024 07:00 AM Precision BioSciences to Effect a Reverse Stock Split

Feb 5, 2024 04:49 PM Form SC 13G PRECISION BIOSCIENCES Filed by: TANG CAPITAL PARTNERS LP

Jan 23, 2024 07:19 PM Form 4 PRECISION BIOSCIENCES For: Jan 20 Filed by: Kelly John Alexander

Jan 23, 2024 07:17 PM Form 4 PRECISION BIOSCIENCES For: Jan 20 Filed by: Amoroso Michael

Jan 23, 2024 07:15 PM Form 4 PRECISION BIOSCIENCES For: Jan 20 Filed by: Scimeca Dario

Jan 23, 2024 07:14 PM Form 4 PRECISION BIOSCIENCES For: Jan 20 Filed by: List Alan

Jan 23, 2024 07:11 PM Form 4 PRECISION BIOSCIENCES For: Jan 20 Filed by: SMITH J. JEFFERSON

Jan 23, 2024 05:30 PM Form 8-K PRECISION BIOSCIENCES For: Jan 22

Jan 23, 2024 04:28 PM Form 144 PRECISION BIOSCIENCES Filed by: SMITH J. JEFFERSON

Jan 22, 2024 03:46 PM Form 144 PRECISION BIOSCIENCES Filed by: Amoroso Michael